Crown Bio launches new feature for XenoBase in vitro models

By Melissa Fassbender contact

- Last updated on GMT

(Image: iStock/Usere6035d91_515)
(Image: iStock/Usere6035d91_515)

Related tags: Pathology

Crown Bioscience has published an updated version of its XenoBase, an online database collating cell line and cell line derived xenograft model data.

According to the company, the new module supplements existing search options in addition to proprietary histopathology, in vivo pharmacology, tumor growth, and molecular pathology data.

With the update, users will be able to search and interact with dose response curves and IC50​ data for more than 290 cell lines.

Qian Shi, Ph.D., vice president of cancer pharmacology and in vitro cancer biology at CrownBio said, “Getting instant access to in vitro pharmacology data linked to in vivo data from the corresponding cell line derived xenograft in one comprehensive and easy-to-browse platform means clients will be able to plan their studies with an end-to-end solution in mind​.”

Related topics: Preclinical Research, Preclinical

Related news

Show more

Related product

Global Clinical Trial Lab Services

Global Clinical Trial Lab Services

Q² Solutions | 01-Apr-2020 | Product Presentation

As a leading global lab services partner, we provide operational excellence, scientific leadership and innovation through technology. We offer end-to-end...

Related suppliers

Follow us

Products

View more

Webinars